Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

PAION reports successful meta-analysis for pain drug M6G

Nov. 4, 2008

Recent GSK, Pfizer and Roche patents disclose new antipsychotic agents

Nov. 4, 2008

FDA approves new indication for Hospira's Precedex in nonintubated patients

Nov. 3, 2008

Galapagos and CHDI sign new collaboration agreements in Huntington's disease

Nov. 3, 2008

Cipher provides update on CIP-Tramadol ER regulatory filing

Oct. 30, 2008

Recent patents divulge novel analgesic agents

Oct. 30, 2008

UCB's Vimpat approved by FDA as adjunctive therapy for seizures

Oct. 29, 2008

New agents for neuropsychiatric disorders reported in recent Actelion and Abbott patents

Oct. 29, 2008

Minster announces results from phase II trial of tonabersat for migraine with aura

Oct. 29, 2008

NeuroSearch initiates dosing in HART study of ACR-16 in Huntington's disease

Oct. 29, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...